Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β-cell damage

Diabetes

Volumn 49, Issue 1, 2000, Pages 39-47

  Zumsteg, Urs ^a   Frigerio, Simona ^a   Holländer, Georg A ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; FLOW CYTOMETRY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0033960945     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.1.39     Document Type: Article

References (52)

1. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542, 1994
2. Hitchcock CL, Riley WJ, Maclaren NK: Autoimmunity in insulin-dependent diabetes mellitus: its detection and prevention. Concepts Immunopathol 5:144-167, 1988
3. Lernmark A, Barmeier H, Dube S, Hagopian W, Karlsen A, Wassmuth R: Autoimmunity of diabetes. Endocrinol Metab Clin North Am 20:589-617, 1991
4. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O: Macrophages, T-cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:1901-1910, 1992
5. Oschilewski U, Kiesel U, Kolb H: Administration of silica prevents diabetes in BB-rats. Diabetes 34:197-199, 1985
6. + T-cells from diabetic versus prediabetic NOD.NON-Thy-la donors. Diabetes 42:44-55, 1993
7. Jutte NH, Heyse P, Bruining GJ, Zeilmaker GH, Weimar W: Effect of cyclosporin A on glucose-induced insulin secretion by isolated human islets of Langerhans. Transplant Proc 19:4152-4153, 1987
8. Assan R, Feutren G, Sirmai J, Laborie C, Boitard C, Vexiau P, Du Rostu H, Rodier M, Figoni M, Vague P, Hors J, Bach J-F: Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin. Diabetes 39:768-774, 1980
9. Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J: Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40:424-429, 1985
10. Corbett JA, Wang JL, Sweetland MA, Lancaster JR Jr, McDaniel ML: Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans: evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 90:2384-2391, 1992
11. Cetkovic Cvrlje M, Eizirik DL: TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399-406, 1994
12. Argiles JM, Lopez Soriano J, Ortiz MA, Pou JM, Lopez Soriano FJ: Interleukin-1 and beta-cell function: more than one second messenger? Endocr Rev 13:515-524, 1992
13. Corbett JA, McDaniel ML: Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
14. Hramiak IM, Dupre J, Finegood DT: Determinants of clinical remission in recent-onset IDDM. Diabetes Care 16:125-132, 1993
15. Southern C, Schulster D, Green IC: Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276:42-44, 1990
16. Dunger A, Cunningham JM, Delaney CA, Lowe JE, Green MH, Bone AJ, Green IC: Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets: extent of nitric oxide involvement. Diabetes 45:183-189, 1996
17. Corbett JA, McDaniel ML: Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903, 1992
18. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom C: Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93:1968-1974, 1994
19. Eizirik DL, Flodstrom M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
20. Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H, and the DENIS Group: The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. Diabetes 47:980-984, 1998
21. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
22. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963, 1997
23. Stokes TA: Constitutive expression of FasL and thyrocytes. Science 279:2015, 1998
24. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Moller P: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429, 1993
25. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo Monte A, Buscemi G, Galluzzo A, Giordano C: Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human beta-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27:3271-3275, 1995
26. Stassi G, Maria RD, Trucco G, Rudert W, Testi R, Galluzzo A, Giordano C, Trucco M: Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 186:1193-1200, 1997
27. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92:10688-10692, 1995
28. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809, 1993
29. Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A: Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol 25:2253-2258, 1995
30. Hara Y, Taniguchi H, Yamashiro Y, Kuroda N, Ishihara K, Ejiri K, Baba S: An improved method for the isolation of islets from the rat pancreas. Exp Clin Endocrinol 91:171-175, 1988
31. Hamaguchi K, Gaskins HR, Leiter EH: NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842-849, 1991
32. 15N]nitrate in biological fluids. Anal Biochem 126:131-138, 1982
33. Harrison M, Dunger AM, Berg S, Mabley J, John N, Green MH, Green IC: Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: role of Fas. FEBS Lett 435:207-210, 1998
34. Gong J, Traganos F, Darzynkiewicz Z: A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218:314-319, 1994
35. Huschtscha LI, Jeitner TM, Andersson CE, Bartier WA, Tattersall MH: Identification of apoptotic and necrotic human leukemic cells by flow cytometry. Exp Cell Res 212:161-165, 1994
36. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML: Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A 90:1731-1735, 1993
37. Berke G: T-cell-mediated cytotoxicity. Curr Opin Immunol 3:320-325, 1991
38. French LE, Tschopp J: Constitutive Fas ligand expression in several nonlymphoid mouse tissues: implications for immune-protection and cell turnover. Behring Inst Mitt (97): 156-160, 1996
39. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
40. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530, 1994
41. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
42. Signore A, Annovazzi A, Gradini R, Liddi R, Ruberti G: Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes Diabetes Metab Rev 14:197-206, 1998
43. Signore A, Annovazzi A, Procaccini E, Beales PE, Spencer J, Testi R, Ruberti G: CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. Diabetologia 40:1476-1479, 1997
44. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A: Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Diabetes 48:21-28, 1999
45. Loweth AC, Williams GT, James RF, Scarpello JH, Morgan NG: Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1β and Fas ligation. Diabetes 47:727-732, 1998
46. Giordano C, Richiusa P, Sbriglia MS, Pizzolanti G: The role of FAS/FASlig and apoptosis in beta-cell death in animal models: relevance for human IDDM. Diabetes Metab Rev 14:194-195, 1998
47. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y: Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp; Med 186:613-618, 1997
48. Genaro AM, Hortelano H, Alvarez A, Martinez C, Bosca L: Splenic B lymphocyte programmed cell death Ls prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95:1884-1890, 1995
49. Mannick JB, Miao XQ, Stamler JS: Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272:24125-24128, 1997
50. Iwahashi H, Hanafusa T, Eguchi Y, Nakajima H, Miyagawa J, Itoh N, Tomita K, Namba M, Kuwajima M, Noguc-hi T, Tsujimoto Y, Matsuzawa Y: Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39:530-536, 1996
51. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 89:3030-3034, 1992
52. Fisher GL, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995